1. A phase 2 trial of dacomitinib (PF‐00299804), an oral, irreversible pan‐HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non–small cell lung cancer after failure of prior chemotherapy and erlotinib. Issue 8 (5th February 2014) Authors: Reckamp, Karen L.; Giaccone, Giuseppe; Camidge, D. Ross; Gadgeel, Shirish M.; Khuri, Fadlo R.; Engelman, Jeff A.; Koczywas, Marianna; Rajan, Arun; Campbell, Alicyn K.; Gernhardt, Diana; Ruiz‐Garcia, Ana; Letrent, Stephen; Liang, Jane; Taylor, Ian; O'Connell, Joseph P.; Jänne, Pasi A. Journal: Cancer Issue: Volume 120:Issue 8(2014) Page Start: 1145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 2 trial of dacomitinib (PF‐00299804), an oral, irreversible pan‐HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non–small cell lung cancer after failure of prior chemotherapy and erlotinib. Issue 8 (5th February 2014) Authors: Reckamp, Karen L.; Giaccone, Giuseppe; Camidge, D. Ross; Gadgeel, Shirish M.; Khuri, Fadlo R.; Engelman, Jeff A.; Koczywas, Marianna; Rajan, Arun; Campbell, Alicyn K.; Gernhardt, Diana; Ruiz‐Garcia, Ana; Letrent, Stephen; Liang, Jane; Taylor, Ian; O'Connell, Joseph P.; Jänne, Pasi A. Journal: Cancer Issue: Volume 120:Issue 8(2014) Page Start: 1145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of Long-Term LMWH on Post-thrombotic Syndrome in Patients With Iliac/Noniliac Venous Thrombosis: A Subanalysis From the Home-LITE Study. (September 2013) Authors: Hull, Russell D.; Liang, Jane; Merali, Tazmin Journal: Clinical and applied thrombosis/hemostasis Issue: Volume 19:Number 5(2013) Page Start: 476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer. (January 2013) Authors: Boyer, Michael; Jänne, Pasi Antero; Mok, Tony; O'Byrne, Kenneth; Paz-Ares, Luis; Ramalingam, Suresh S; Liang, Jane; Taylor, Ian; Campbell, Alicyn; O'Connell, Joseph; Letrent, Stephen; Antic, Vladan Journal: Clinical investigation Issue: Volume 3:Number 1(2013) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer. (January 2013) Authors: Boyer, Michael; Jänne, Pasi Antero; Mok, Tony; O'Byrne, Kenneth; Paz-Ares, Luis; Ramalingam, Suresh S; Liang, Jane; Taylor, Ian; Campbell, Alicyn; O'Connell, Joseph; Letrent, Stephen; Antic, Vladan Journal: Clinical investigation Issue: Volume 3:Number 1(2013) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Venous Thromboembolism in Elderly High-Risk Medical Patients: Time Course of Events and Influence of Risk Factors. (July 2013) Authors: Hull, Russell D.; Merali, Tazmin; Mills, Allan; Stevenson, Abigail L.; Liang, Jane Journal: Clinical and applied thrombosis/hemostasis Issue: Volume 19:Number 4(2013) Page Start: 357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗